A Patient-Derived Organ-on-Chip Platform for Modeling the Tumor Microenvironment and Drug Responses in Pancreatic Cancer.

Adv Sci (Weinh) · 2026 · PMC12970226 · PMID 41610338

Europe PMC DOI

hedged sentence

0.0720

closest p · 1.4× alpha

0.0720

boldest claim

The sentences

showed a trendp = 0.072so close (0.05 < p ≤ 0.1)

IL‐1β showed a trend at 1 h (2.197 ± 0.474 vs 4.512 ± 0.139, p = 0.072) and was significantly higher at 6 h (2.525 ± 0.199 vs 6.416 ± 0.258, p = 0.0090) and 24 h (2.433 ± 0.061 vs 6.839 ± 0.004, p = 0.0090).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.